Edward Wholihan - Net Worth and Insider Trading

Edward Wholihan Net Worth

The estimated net worth of Edward Wholihan is at least $0 dollars as of 2024-05-12. Edward Wholihan is the CFO of Allena Pharmaceuticals Inc and owns about 189,822 shares of Allena Pharmaceuticals Inc (ALNAQ) stock worth over $0. Details can be seen in Edward Wholihan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Edward Wholihan has not made any transactions after 2020-12-17 and currently still holds the listed stock(s).

Transaction Summary of Edward Wholihan

To

Edward Wholihan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edward Wholihan owns 2 companies in total, including Allena Pharmaceuticals Inc (ALNAQ) , and KORU Medical Systems Inc (KRMD) .

Click here to see the complete history of Edward Wholihan’s form 4 insider trades.

Insider Ownership Summary of Edward Wholihan

Ticker Comapny Transaction Date Type of Owner
ALNAQ Allena Pharmaceuticals Inc 2020-12-17 Chief Financial Officer
KRMD KORU Medical Systems Inc 2023-09-28 director

Edward Wholihan Latest Holdings Summary

Edward Wholihan currently owns a total of 1 stock. Edward Wholihan owns 189,822 shares of Allena Pharmaceuticals Inc (ALNAQ) as of December 17, 2020, with a value of $0.

Latest Holdings of Edward Wholihan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALNAQ Allena Pharmaceuticals Inc 2020-12-17 189,822 0.00 0

Holding Weightings of Edward Wholihan


Edward Wholihan Form 4 Trading Tracker

According to the SEC Form 4 filings, Edward Wholihan has made a total of 1 transactions in Allena Pharmaceuticals Inc (ALNAQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Allena Pharmaceuticals Inc is the sale of 68,550 shares on December 17, 2020, which brought Edward Wholihan around $93,228.

Insider Trading History of Edward Wholihan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Edward Wholihan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Edward Wholihan Ownership Network

Ownership Network List of Edward Wholihan

No Data

Ownership Network Relation of Edward Wholihan


Edward Wholihan Owned Company Details

What does Allena Pharmaceuticals Inc do?

Who are the key executives at Allena Pharmaceuticals Inc?

Edward Wholihan is the Chief Financial Officer of Allena Pharmaceuticals Inc. Other key executives at Allena Pharmaceuticals Inc include See Remarks Louis Md Brenner , Chief Financial Officer Richard D Katz , and 10 percent owner Bessemer Venture Partners Vii L.p. .

Allena Pharmaceuticals Inc (ALNAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Allena Pharmaceuticals Inc (ALNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Allena Pharmaceuticals Inc (ALNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Allena Pharmaceuticals Inc (ALNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Allena Pharmaceuticals Inc Insider Transactions

No Available Data

Edward Wholihan Mailing Address

Above is the net worth, insider trading, and ownership report for Edward Wholihan. You might contact Edward Wholihan via mailing address: C/o Allena Pharmaceuticals, Inc., One Newtown Executive Park Suite 202, Newton Ma 02462.

Discussions on Edward Wholihan

No discussions yet.